Skip to content

Brevel develops alternative protein from microalgae using a process that combines fermentation and light.

Introduce me to Brevel
Brevel website sharing image

Image source: company website sharing image

Founders & company facts

Sources reviewed:

Reported cumulative funding

$35,900,000 · Source

This index includes companies with publicly reported total funding up to US$150 million. This is a reported total, not valuation, the latest round size or confirmation of an open round. Funding reviewed: .

Documented founding team

Founded
2017Source
Reported Israeli location
Kiryat GatSource
Team range in directory
11-50Source
Reported business model
B2B, B2B2CSource

Selected disclosed financing

Selected transactions, with dates, funding types and reported participants.

  1. May 2026$1MNon-equity funding
    Named participants

    BIRD Foundation

    Source
  2. Mar 2025$12.5MSeed
    Named participants

    NevaTeam Partners · Good Protein Fund · PVS Investments · Siddhi Capital · European Union’s EIC Fund · theFoodTechLab

    Source

Company overview

Product & customers

Brevel develops alternative protein from microalgae using a process that combines fermentation and light. Its ingredients target food manufacturers seeking functional protein for products such as dairy alternatives.

Commercial potential · editorial analysis

The commercial opportunity is supplying ingredients to established food brands instead of building every consumer product internally, with demand linked to formulation performance. Investors should distinguish paid use and renewals from pilots, and examine how sales and delivery costs change as deployments expand.

What to validate

Diligence should focus on production costs at commercial scale, sensory performance, regulatory clearance and binding demand rather than sample requests. Evidence should come from representative customer deployments, with costs, limitations and failure cases reported alongside successful results.

Product source reviewed on . Company source